I

Innovent Biologics Inc/ADR

0001774163

Unfortunately, I am unable to retrieve sufficient information to generate meaningful translations or descriptions based on the single company name provided. Providing more context about the company would enable me to populate all the desired fields.

65
Moderat Pålitelig
Tillitsscore

Offisielt Register

MVA Nummer
000000000
Adresse
120 BROADWAY, NEW YORK, NY 10271
Bransjekoder
Unknown

AI Kvalitetsanalyse

Bransje
Pharmaceuticals
SSL/HTTPS
Sikker
Profesjonell E-post
Nei

Tillitsscore Detaljer

Register Verifisert35/35
Kvalitetsscore30/60
Nyhetsanalyse0/5

Nettside Høydepunkter

Sist oppdatert: 1/2/2026

🌟 Lignende Pålitelige Bedrifter

Olema Pharmaceuticals, Inc.

Olema Pharmaceuticals, Inc. logo
71/100 · Pålitelig

Olema Oncology is a pharmaceutical company focused on developing innovative medicines. They specialize in the treatment of breast cancer and other cancers. Their goal is to improve patients' quality of life through better treatments. Olema is listed on Nasdaq.

780 BRANNAN STREET, USA
Se profil

NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals, Inc. logo
89/100 · Meget Pålitelig

We are a pharmaceutical company focused on scientifically created and clinically proven eyecare and skincare products. We also manufacture and sell NeutroPhase, a proprietary hypochlorous acid for the wound care market, used for cleansing wounds. Our product NeutroPhase is distributed in China by Pioneer Pharma (Hong Kong) Company Ltd.

2000 POWELL STREET, USA
Se profil

ACHIEVE LIFE SCIENCES, INC.

ACHIEVE LIFE SCIENCES, INC. logo
86/100 · Meget Pålitelig

Achieve Life Sciences is a specialty pharmaceutical company focused on tackling the global nicotine dependence epidemic. Their key product, cytisinicline, is being developed as a treatment option for smoking cessation. Achieve's New Drug Application for cytisinicline has been accepted by the FDA, with a PDUFA date set for June 20, 2026, potentially offering the first new FDA-approved treatment in nearly 20 years.

22722 29TH DR. SE, USA
Se profil